Overview
Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
Status:
Recruiting
Recruiting
Trial end date:
2025-03-20
2025-03-20
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
GnRH antagonist protocol is currently a good strategy for controlled ovarian stimulation in women with PCOS undergoing IVF/ICSI cycles. Finding a protocol that can be a better alternative will help in improving the success rate of IVF/ICSI cyclesPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Zagazig UniversityTreatments:
Cetrorelix
Dydrogesterone
Progestins
Criteria
Inclusion Criteria:1. All patients should be candidates for ICSI.
2. Age between 20-40 years.
3. Body mass index 18-35 kg/m2.
4. Diagnosis of PCOS according to modified Rotterdam's criteria
Exclusion Criteria:
- 1) Any patient with contraindication to IVF treatment or pregnancy 2) Women with
history of intra-uterine abnormality. 3) Severe endometriosis (grade 3 or 4) 4)
Clinically significant systemic disease or other endocrinopathy.